Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 985.00
-19.40 (-1.93%)
May 15, 2026, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 156.22 billion as of May 15, 2026. Its market cap has increased by 8.33% in one year.
Market Cap
156.22B
Enterprise Value
178.62B
Revenue
79.18B
Ranking
n/a
PE Ratio
36.10
Stock Price
985.00
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 156.22B, an increase of 38,308.38%. That is a compound annual growth rate of 25.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 156.22B | -8.23% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 317.70B |
| Gland Pharma | 312.74B |
| Wockhardt | 251.41B |
| Piramal Pharma | 232.20B |
| NATCO Pharma | 214.77B |
| Eris Lifesciences | 184.35B |
| Cohance Lifesciences | 161.90B |
| Alembic Pharmaceuticals | 154.44B |